CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL NYSE CIK: 0001100682

Company Information

Industry Services-Commercial Physical & Biological Research
SIC Code 8731
Entity Type operating
SEC Category Large accelerated filer
Business Address 251 BALLARDVALE ST, WILMINGTON, MA, 01887
Mailing Address 251 BALLARDVALE ST, WILMINGTON, MA, 01887
Phone 781-222-6000
Fiscal Year End 1227
EIN 061397316

Financial Overview

FY2025

$7.53B
Total Assets

Recent SEC Filings

Form Type Date Filed Document
DEF 14A Definitive proxy statement March 31, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment March 26, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
8-K Current report of material events February 25, 2026 View on SEC
8-K Current report of material events February 18, 2026 View on SEC
8-K Current report of material events February 18, 2026 View on SEC
10-K Annual financial report February 18, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 12, 2026 View on SEC

Annual Reports

10-K February 18, 2026
  • Solid 2024 financial performance with 3.2% revenue growth to $4.52 billion and 3.8% operating income growth.
  • Strategic acquisitions like SAMDI Tech and Noveprim Group expanded capabilities and secured critical supply chains, with significant future revenue contributions.
View Analysis

Insider Trading

BUY 1 insiders 1 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 8731)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.